Shankland named CMPMedica CEO

Share this article:
CMPMedica named Sally Shankland CEO of CMPMedica US, replacing Vicki Masseria.

Shankland was previously SVP of the firm's US promotional business unit, a role she served for six years. She has worked for CMPMedica owner United Business Media since 1988, when she joined Miller Freeman. She orchestrated the 2006 launch of SearchMedica. Harry Elkington, global CEO of CMPMedica, praised her “great track record in building the promotional side of our business.”
Masseria spent 26 years with CMPMedica and its predecessor companies. Through a CMPMedica spokesperson, she declined comment on her future plans.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Judge blocks FDA bid to allow generic Precedex

Judge blocks FDA bid to allow generic Precedex

The US District Court for Maryland granted Hospira a temporary restraining order (TRO) against FDA, after the agency determined that potential generic competitors of the company's injectable sedation drug Precedex ...

GSK drug gets aplastic anemia indication

GSK drug gets aplastic anemia indication

Promacta was previously indicated for chronic immune thrombocytopenia.

Five things for Pharma Marketers to know: Wednesday, August 27

Five things for Pharma Marketers to know: Wednesday, ...

Allergan sets a shareholder voting date, Novo describes the types of acquisitions it will consider, and the AstraZeneca-Pfizer talks can now reopen.